Get the Stockscreener App
0.411
0.77%
-0.0032
After Hours:
.40
-0.011
-2.68%
Acurx Pharmaceuticals Inc Stock (ACXP) Forecast
The Acurx Pharmaceuticals Inc (ACXP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.548, representing a +276.65% increase from the current price of $0.411. The highest analyst price target is $2.0424, and the lowest is $1.0537.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACXP Price Target
Average 1.6716
(+306.71% Upside)
Is Acurx Pharmaceuticals Inc (ACXP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 54.02 | Neutral |
| STOCH(9,6) | 49.83 | Neutral |
| STOCHRSI(14) | 95.88 | Sell |
| MACD(12,26) | -0.0022 | Buy |
| ADX(14) | 19.55 | Neutral |
| William %R | -37.28 | Neutral |
| CCI(14) | 83.66 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3871
Buy
|
0.3936
Buy
|
| MA20 |
0.3929
Buy
|
0.3909
Buy
|
| MA50 |
0.3918
Buy
|
0.4423
Sell
|
| MA100 |
0.5744
Sell
|
0.6381
Sell
|
| MA200 |
1.1587
Sell
|
1.0809
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ACXP could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on ACXP, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 54.02 indicates that ACXP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 49.83 indicates that ACXP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 95.88 indicates that ACXP is oversold. This suggests that ACXP price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.55 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 83.66 indicates that ACXP is still overbought but not to an extreme extent.
Long-term ACXP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acurx Pharmaceuticals Inc financial reports and earnings history, Acurx Pharmaceuticals Inc (ACXP) stock could reach $2.7574 by 2030, $10.98 by 2040 and $17.62 by 2050. See the projected annual prices until 2050 of the Acurx Pharmaceuticals Inc stock below:
- Acurx Pharmaceuticals Inc (ACXP) is expected to reach an average price of $5.1518 in 2035, with a high prediction of $4.7235 and a low estimate of $4.4538. This indicates an $1,153% rise from the last recorded price of $0.411.
- Acurx Pharmaceuticals Inc (ACXP) stock is projected to chart a bullish course in 2040, with an average price target of $11.04, representing an $2,586% surge from its current level. The forecast ranges from a conservative $3.8543 to a sky-high $10.98.
- Our analysts predict Acurx Pharmaceuticals Inc (ACXP) to jump 2,072% by 2045, soaring from $9.3923 to an average price of $8.9284, potentially reaching $8.9184. While $9.3923 is the low estimate, the potential upside is significant.
- Acurx Pharmaceuticals Inc (ACXP) stock is expected to climb by 2050, reaching an average of $17.29, a $4,107% jump from its current level. However, a wide range of estimates exists, with high and low targets of $17.62 and $17.48, respectively, highlighting the market's uncertainty.
Acurx Pharmaceuticals Inc Stock (ACXP) Year by Year Forecast
Acurx Pharmaceuticals Inc Stock (ACXP) Price Forecast for 2025
Acurx Pharmaceuticals Inc Stock (ACXP) is expected to reach an average price of $1.4237 in 2025, with a high prediction of $2.7412 and a low estimate of $0.1061. This indicates an +246.39% rise from the last recorded price of $0.411.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $1.8024 | $1.0537 | $2.0424 | +338.53% |
| July, 2025 | $1.3066 | $1.1578 | $2.7412 | +217.92% |
| August, 2025 | $0.962 | $0.9532 | $2.5443 | +134.08% |
| September, 2025 | $1.2875 | $0.7886 | $1.4707 | +213.25% |
| October, 2025 | $0.9617 | $0.6052 | $1.6229 | +134.00% |
| November, 2025 | $1.9071 | $0.9506 | $2.0771 | +364.03% |
| December, 2025 | $2.3314 | $1.692 | $2.7137 | +467.25% |
Acurx Pharmaceuticals Inc Stock (ACXP) Price Forecast for 2026
The predicted value for Acurx Pharmaceuticals Inc (ACXP) in 2026 is set at an average of $3.6848. Estimates vary from a peak of $7.3221 to a trough of $0.0476, indicating an +796.56% surge from the present price of $0.411.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.6568 | $1.5468 | $2.6503 | +303.12% |
| February, 2026 | $1.7922 | $1.1945 | $1.9422 | +336.07% |
| March, 2026 | $1.6877 | $1.21 | $2.0911 | +310.62% |
| April, 2026 | $1.2619 | $0.6019 | $1.7954 | +207.04% |
| May, 2026 | $1.4073 | $1.1474 | $1.6908 | +242.42% |
| June, 2026 | $0.9128 | $0.8628 | $1.6362 | +122.08% |
| July, 2026 | $0.307 | $0.107 | $1.1005 | -25.30% |
| August, 2026 | $0.2824 | $0.0476 | $0.5955 | -31.28% |
| September, 2026 | $0.2367 | $0.1367 | $0.6313 | -42.41% |
| October, 2026 | $2.8421 | $0.0644 | $7.3221 | +591.51% |
| November, 2026 | $1.8175 | $1.6175 | $5.1609 | +342.22% |
| December, 2026 | $2.3718 | $1.3564 | $2.4852 | +477.08% |
Acurx Pharmaceuticals Inc Stock (ACXP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acurx Pharmaceuticals Inc (ACXP) is $1.9685, with a high forecast of $3.9149 and a low forecast of $0.0221. This indicates an +378.96% increase from the last price of $0.411.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.4472 | $1.6795 | $3.2457 | +495.43% |
| February, 2027 | $2.5226 | $2.0038 | $3.9149 | +513.78% |
| March, 2027 | $1.8469 | $1.448 | $2.6015 | +349.37% |
| April, 2027 | $1.4523 | $1.4323 | $2.0558 | +253.36% |
| May, 2027 | $0.5377 | $0.4278 | $1.6611 | +30.83% |
| June, 2027 | $0.48 | $0.2966 | $1.1243 | +16.79% |
| July, 2027 | $0.5708 | $0.1692 | $0.7108 | +38.89% |
| August, 2027 | $0.0167 | $0.3615 | $0.6885 | -95.95% |
| September, 2027 | $0.0402 | $0.1506 | $0.3702 | -90.22% |
| October, 2027 | $0.089 | $0.0221 | $0.6856 | -78.35% |
| November, 2027 | $0.4781 | $0.2813 | $0.5387 | +16.34% |
| December, 2027 | $1.1796 | $0.5726 | $0.2411 | +187.01% |
Acurx Pharmaceuticals Inc Stock (ACXP) Price Forecast for 2028
In 2028, Acurx Pharmaceuticals Inc (ACXP) is projected to reach an average price of $0.9208, with a high projection of $1.73 and a low estimate of $0.1116. This indicates an +124.04% rise from the last price of $0.411.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6688 | $0.7881 | $0.8119 | +62.72% |
| February, 2028 | $1.108 | $0.8709 | $1.0558 | +169.57% |
| March, 2028 | $1.1794 | $1.0025 | $1.1694 | +186.96% |
| April, 2028 | $0.7886 | $0.8363 | $0.9117 | +91.87% |
| May, 2028 | $1.74 | $0.9589 | $1.73 | +323.37% |
| June, 2028 | $0.6692 | $0.8592 | $1.7123 | +62.83% |
| July, 2028 | $0.6634 | $0.6962 | $0.5884 | +61.41% |
| August, 2028 | $0.3299 | $0.1116 | $0.6324 | -19.74% |
| September, 2028 | $0.231 | $0.759 | $0.5767 | -43.80% |
| October, 2028 | $0.6582 | $0.3425 | $0.6259 | +60.14% |
| November, 2028 | $1.0097 | $0.9274 | $0.7497 | +145.66% |
| December, 2028 | $0.7088 | $0.9742 | $0.7923 | +72.46% |
Acurx Pharmaceuticals Inc Stock (ACXP) Price Forecast for 2029
The 2029 price forecast for Acurx Pharmaceuticals Inc Stock (ACXP) is $2.9157 on average, with a high prediction of $5.8242 and a low estimate of $0.00717. This represents an +609.42% increase from the previous price of $0.411.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1697 | $0.0497 | $0.5311 | -58.71% |
| February, 2029 | $0.1005 | $0.00717 | $0.8174 | -75.54% |
| March, 2029 | $0.00873 | $0.1518 | $0.2724 | -97.87% |
| April, 2029 | $0.1678 | $0.3978 | $0.2922 | -59.17% |
| May, 2029 | $0.5493 | $0.177 | $0.1353 | +33.64% |
| June, 2029 | $0.4084 | $0.4284 | $0.4061 | -0.62% |
| July, 2029 | $0.4476 | $0.4863 | $0.303 | +8.91% |
| August, 2029 | $0.8691 | $0.5999 | $0.5668 | +111.45% |
| September, 2029 | $1.1782 | $1.1314 | $1.0982 | +186.68% |
| October, 2029 | $1.1897 | $1.2674 | $1.2151 | +189.47% |
| November, 2029 | $1.5189 | $1.352 | $1.2849 | +269.56% |
| December, 2029 | $2.202 | $1.022 | $5.8242 | +435.75% |
Acurx Pharmaceuticals Inc Stock (ACXP) Price Forecast for 2030
Acurx Pharmaceuticals Inc Stock (ACXP) is expected to reach an average price of $1.5953 in 2030, with a high forecast of $3.0934 and a low forecast of $0.0972. This signifies an +288.16% surge from the last price of $0.411.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8105 | $0.0972 | $2.7574 | +97.20% |
| February, 2030 | $1.1813 | $0.6059 | $1.8363 | +187.43% |
| March, 2030 | $1.1521 | $0.279 | $1.4421 | +180.33% |
| April, 2030 | $0.593 | $0.513 | $2.5499 | +44.28% |
| May, 2030 | $0.2815 | $0.1361 | $0.7615 | -31.51% |
| June, 2030 | $0.5777 | $0.1646 | $0.5992 | +40.55% |
| July, 2030 | $0.3591 | $0.5291 | $0.4745 | -12.62% |
| August, 2030 | $3.5234 | $0.2637 | $3.0934 | +757.28% |
| September, 2030 | $2.7872 | $2.7738 | $2.7969 | +578.15% |
| October, 2030 | $3.5544 | $2.711 | $2.7903 | +764.82% |
| November, 2030 | $2.2081 | $2.5381 | $2.6278 | +437.26% |
| December, 2030 | $2.6419 | $2.6916 | $2.2886 | +542.80% |
1.52%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):